News Snapshot:
Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia Providence grants Everest license to develop and market potentially «Best-In-Class» mRNA COVID-19 vaccine for select Asia territories Providence and Everest… Providence grants Everest license to develop and market potentially «Best-In-Class» mRNA COVID-19 vaccine for select Asia territories Providence and Everest enter into a 50/50 worldwide collaboration to jointly develop products in two additional indications, leveraging Providence’s cutting-edge mRNA technology Providence will receive $100 million USD upfront, up to 12% equity position in Everest based upon milestones, and...
